Website preview: Demonstration inquiries use your email app. The business mailbox must be activated and tested before public launch. Security, deployment, and integration claims are subject to verification.
BUILDING THE FUTURE OF PHARMA QUALITY

Quality decisions.
Better informed.

Purpose-built digital technology for pharmaceutical quality teams. Meet AuditLens — designed to bring structure, traceability and clarity to electronic audit-trail review.

Pre-commercial evaluation · Early demonstrations targeted for November 2026

QUALITY INTELLIGENCE ILLUSTRATIVE CONCEPT
AUDITLENS / REVIEW WORKSPACE◉
RULE-DRIVENReview
DOCUMENTEDAssessment
CONTROLLEDDecision
✧ Designed for traceable quality workflows
Product status: AuditLens is under development and testing. Read-only Waters Empower connectivity and production deployment are not yet verified.
BUILT AROUND THE NEEDS OF REGULATED LABORATORIES
Pharmaceutical QCData IntegrityGxP WorkflowsChromatographyQuality Oversight
01 / OUR STORY

Built around real laboratory challenges.

QualityAdmit is an emerging pharmaceutical software brand informed by more than 15 years of practical experience in pharmaceutical quality control and regulated laboratory workflows.

Our aim is to develop clear, controlled digital tools that support review consistency, accountability and quality decision-making.

Founder experience is described in general terms. QualityAdmit is not presented as an incorporated entity or a certified software vendor.
03 / SOLUTIONS

Technology shaped by quality needs.

Review consistency

Support a repeatable approach to evaluating relevant audit-trail events.

Defined accountability

Clarify reviewer, QA and master-rule ownership responsibilities.

Traceable outcomes

Document event assessment and the rationale for review decisions.

04 / RESPONSIBLE DEVELOPMENT

Designed for regulated environments.
Built to earn trust.

Our development priorities include access controls, traceability, verification, and practical quality workflows. Formal validation and customer-specific qualification remain essential before regulated use.

Read our security and compliance approach ↗
PRODUCT RESOURCE

AuditLens one-page overview

Share a concise product introduction with your quality and laboratory teams.

Download PDF ↓
05 / LET'S CONNECT

Explore an early AuditLens demonstration.

For pharmaceutical quality teams, laboratories and potential technology partners.

Talk to QualityAdmit

Tell us about your interest. During this preview stage, the inquiry form opens a pre-filled email rather than sending data to a server.

Request a Demo ↗
AUDITLENS · PRODUCT DETAILS
01 / WHY IT MATTERS

Bring clarity to audit-trail review.

Event volume

Large volumes of electronic activity can complicate consistent, risk-based review.

Assessment context

Quality decisions benefit from documented reasoning, not simply a list of events.

Oversight

Clear roles and review status help teams understand responsibilities and next actions.

02 / INTENDED WORKFLOW

Review with structure.

01

Select scope

Define batch-level or system-level audit-trail review scope.

02

Apply rules

Evaluate events against configured criteria and record applicable results.

03

Assess

Support reviewer evaluation and documented rationale.

04

QA decision

Support quality oversight and controlled review outcomes.

Workflow illustration, not a claim that every feature has completed integration testing or validation.

03 / PRODUCT CAPABILITIES

Designed for quality teams.

Configurable Master Rules

Controlled review logic aligned to organizational procedures, with designated QA ownership.

Role-based workspaces

Separate responsibilities for reviewers, QA and authorized master-rule users.

Scope-specific selection

Batch and system selection inputs intended to support relevant review coverage.

Documented review history

Traceability of selection, assessment and decision activities, subject to ongoing verification.

04 / INTEGRATION & DEPLOYMENT

Integration planned.
Validation matters.

Read-only Waters Empower connectivity is a planned integration, not a completed or qualified production connector. Future deployment approaches may include customer-controlled on-premises environments and appropriately secured cloud hosting.

Current status: Pre-commercial development and testing. Security verification, formal validation and production qualification are not complete.

Security & compliance approach ↗

05 / QUESTIONS

Frequently asked questions.

Is AuditLens commercially available today?

Not yet. It is in pre-commercial development and evaluation; demonstrations are planned subject to readiness.

Does AuditLens connect to Waters Empower?

Read-only Empower integration is planned. It is not currently represented as a verified, production-ready connector.

Is AuditLens FDA approved or validated?

No FDA approval or validation claim is made. Product testing and formal validation work remain to be completed. Customers must assess qualification and intended-use requirements.

Can we define our own review rules?

The product is designed around configurable, controlled review criteria. Actual behavior and permissions must be demonstrated and verified in the evaluated build.

Will cloud and on-premises deployment be supported?

Both are potential future options. Availability will depend on technical readiness, security evaluation and deployment qualification.

SECURITY & COMPLIANCE
01 / PRINCIPLES

Controls should be demonstrable.

Access & segregation

Role-based permissions and separation of duties for reviewers, QA decision makers and master-rule owners.

Traceability

Review history and documented rationale to support understanding of decisions.

Controlled configuration

Rule governance, versioning and approvals are design requirements subject to verification.

Data minimization

Planned read-only acquisition from chromatography data systems where feasible and appropriate.

Verification & validation

Risk-based testing and formal validation evidence must precede claims of regulated readiness.

Customer responsibilities

Intended use, SOPs, training, infrastructure and customer qualification require site-specific assessment.

02 / REGULATORY CONTEXT

Developed with regulated workflows in mind.

Our product design considers topics commonly associated with 21 CFR Part 11, EU GMP Annex 11 and ALCOA+ data-integrity principles. These references describe design considerations and do not imply endorsement, certification or compliance verification.

AuditLens is pre-commercial. Security assessment, formal validation, integration qualification and production deployment verification remain pending.
RESOURCES & INSIGHTS
01 / DOWNLOADS

Product overview.

AuditLens — One-Page Brochure

Overview of the challenge, intended review workflow, product status and early demonstration opportunity.

Download PDF ↓

QualityAdmit — Introduction

Our emerging pharmaceutical software brand, purpose and background.

Download PDF ↓
02 / INSIGHTS

Topics we care about.

Risk-based audit-trail review

How structured review criteria can support more focused event evaluation.

ARTICLE PLANNED

Data integrity in chromatography

Practical considerations for controlled electronic records and review accountability.

ARTICLE PLANNED

Traceable QA decisions

Why assessment rationale and clear quality oversight matter.

ARTICLE PLANNED

These are planned editorial topics, not published articles.

REQUEST A DEMONSTRATION
DEMO REQUEST

Tell us about your needs.

Complete the form to prepare an email in your own email application. No information is uploaded or stored by this preview website.

Preview limitation: This is not yet a server-backed form. The business inbox contact@qualityadmit.com must be created and tested before public launch.

Prefer to contact us directly? contact@qualityadmit.com (pending activation)

By choosing the button below, you will open your email app with these details. Review the message before sending. Please do not include confidential or patient data.

PRIVACY & LEGAL